Ciccarese M, Orlando L, Fedele P, Schiavone P, et al. A multicenter phase II trial of nab-paclitaxel and capecitabine in HER-2 negative and triple- negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease? Breast J 2020 May 20. doi: 10.1111/tbj.13856.
PMID: 32436244